The Scientific and Clinical Team at Pipeline Therapeutics is dedicated to advancing the company's mission of developing first-in-class small molecules for neuroregeneration. This team is responsible for conducting cutting-edge research, overseeing clinical trials, and ensuring the scientific integrity and clinical efficacy of therapeutic candidates for synaptogenesis, remyelination, and axonal repair. They collaborate closely to translate scientific discoveries into viable treatments, ultimately aiming to improve patient outcomes in neurodegenerative diseases.
Ari Green
Clinical Advisor
Didier Bagnol, Ph. D...
Director in vivo Pharmacology
Elior Peles
Scientific Advisor
Jonah Chan
Scientific Advisor
Julie Iwashita
VP, Clinical Operations
Karin Stebbins
Director of Pharmacology
Mike Mayberry, CPA
Senior Director, Corporate Con...
Rick Friedman
Clinical Advisor
Stefan Heller
Scientific Advisor
Stephen L. Huhn, MD,...
CMO and SVP, Clinical Developm...
View all